WorkspaceResearch
CPHLPHARMACEUTICALSAlpha Score••Free accountSep-26

Citi Pharma Ltd

Shariah compliant
Last close
Rs62.35
−0.02%
3 monthsAs of 19 Nov
BusinessSlowingGrowthShranklast yearValueCore planHealthSoundDividendSkipped

A sound balance sheet. No dividend last year, the price is in a downtrend and priced above its peers.

Working

  • Debt is 28% of equity in the latest quarter.
  • Profit up 22% on the same quarter last year.
  • Operating margin 14% over the last twelve months, above its average of 12% over the last 3 years.

To watch

  • P/E 17.0 against a sector median of 11.9.
  • Short-term assets cover short-term bills 1.3 times in the latest quarter.
  • Revenue up 4% on the same quarter last year.
Full analysis · free account

Keep reading CPHL: business, price trend and value

How good the business is, where its support zone sits, what it may be worth, its health, dividends, peers and latest results open with a free account.

Latest results

Quarter: Jul–Sep 2026

In the Jul–Sep 2026 quarter, CPHL's sales rose 4% to Rs 3.5bn, from Rs 3.4bn, and profit after tax rose 22% to Rs 248.8mn, from Rs 204.0mn (compared with Jul–Sep 2025).

Earnings per share were Rs 1.09, against Rs 0.89 a year earlier.

At Rs 62.35, CPHL trades at 15.7 times earnings.

P/E ratio
15.7
Dividend yield
0.0%
Dividend payout
0%
of earnings
Return on equity
8%
Net margin
6.0%
last 12 months
Debt to equity
0.28

CPHL quarterly results

Reported figures
QuarterSalesProfit after taxNet marginEPSDividend / share
Jul–Sep 2026Rs 3.5bnRs 248.8mn7.1%Rs 1.09—
Apr–Jun 2026Rs 3.3bn-Rs 92.7mn-2.8%-Rs 0.41—
Jan–Mar 2026Rs 3.1bnRs 275.0mn8.9%Rs 1.21—
Oct–Dec 2025Rs 4.3bnRs 404.0mn9.3%Rs 1.77—
Jul–Sep 2025Rs 3.4bnRs 204.0mn6.1%Rs 0.89—
Apr–Jun 2025Rs 3.1bnRs 214.0mn7.0%Rs 0.94Rs 3.50
Jan–Mar 2025Rs 3.3bnRs 220.0mn6.6%Rs 0.96—
Oct–Dec 2024Rs 3.5bnRs 257.0mn7.3%Rs 1.12—

CPHL annual results and dividends

Reported figures
YearSalesProfit after taxEPSDividend / share
Year to Jun 2026Rs 14.1bnRs 790.3mnRs 3.46—
Year to Jun 2025Rs 13.2bnRs 892.0mnRs 3.90Rs 3.50
Year to Jun 2024Rs 12.4bnRs 833.0mnRs 3.65Rs 3.25
Year to Jun 2023Rs 12.4bnRs 658.0mnRs 2.88Rs 2.50
Year to Jun 2022Rs 9.8bnRs 636.0mnRs 2.78—

Balance sheet and price

Balance sheet as of Sep 2026
Total assets
Rs 18.0bn
Shareholders' equity
Rs 11.1bn
Cash & bank
Rs 270.8mn
Total debt
Rs 3.1bn
Current ratio
1.30
3-month high
Rs 76.67
3-month low
Rs 58.22
1-month change
+1.2%
3-month change
-15.1%

Read more about CPHL

Other pharmaceuticals companies

CPHL: common questions

What is CPHL's share price?

Citi Pharma Ltd (CPHL) last closed at Rs 62.35 on the Pakistan Stock Exchange.

Does CPHL pay a dividend?

Citi Pharma Ltd reported no dividend for the year to Jun 2026.

What were CPHL's latest results?

In the Jul–Sep 2026 quarter, CPHL's sales rose 4% to Rs 3.5bn, from Rs 3.4bn, and profit after tax rose 22% to Rs 248.8mn, from Rs 204.0mn (compared with Jul–Sep 2025).

What is CPHL's P/E ratio?

At Rs 62.35, CPHL trades at 15.7 times its earnings.

Figures are taken from the company's published financial statements and PSX prices. This page is information, not investment advice.